Methylphenidate

Chemical formula: C₁₄H₁₉NO₂  Molecular mass: 233.306 g/mol  PubChem compound: 4158

Therapeutic indications

Methylphenidate is indicated for:

Attention-deficit/hyperactivity disorder (ADHD)

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Methylphenidate is indicated as part of a comprehensive treatment programme for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents 6-17 years old when remedial measures alone prove insufficient.

Treatment must be under the supervision of a specialist in childhood behavioural disorders. Diagnosis should be made according to Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) criteria or the guidelines in International Classification of Diseases, Tenth Revision (ICD-10) and should be based on a complete history and evaluation of the patient. Diagnosis cannot be made solely on the presence of one or more symptoms.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Methylphenidate is contraindicated in the following cases:

Glaucoma

Glaucoma

Lactation

Lactation

Phaeochromocytoma

Phaeochromocytoma

Monoamine oxidase (MAO) inhibitors

Monoamine oxidase inhibitors (MAOIs)

Hyperthyroidism, thyrotoxicosis

at least one of
Hyperthyroidism
Thyrotoxicosis

Severe depression, anorexic disorders, psychotic symptoms, personality disorder

at least one of
Severe depression
H/O: depression
Anorexia nervosa
H/O: anorexia nervosa
Suicidal intent
History of attempted suicide
Psychotic symptom present
Mood disorder
History of mood disorder
Schizophrenia
H/O: schizophrenia
Antisocial personality disorder

Severe and episodic bipolar disorder

at least one of
Bipolar type I disorder currently in full remission
H/O: manic depressive disorder

Cardiovascular disorders

Cardiovascular disorder

Cerebrovascular disorders

at least one of
Cerebrovascular disease
Cerebral aneurysm
Vasculitis
CVA - Cerebrovascular accident
At risk of cerebrovascular accident

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈